Logo image of AHCO

ADAPTHEALTH CORP (AHCO) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:AHCO - US00653Q1022 - Common Stock

10.6 USD
+0.11 (+1.05%)
Last: 1/12/2026, 8:00:00 PM
10.6 USD
0 (0%)
After Hours: 1/12/2026, 8:00:00 PM
Fundamental Rating

4

AHCO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of AHCO while its profitability can be described as average. AHCO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

AHCO had positive earnings in the past year.
AHCO had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AHCO reported negative net income in multiple years.
AHCO had a positive operating cash flow in each of the past 5 years.
AHCO Yearly Net Income VS EBIT VS OCF VS FCFAHCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

AHCO has a Return On Assets of 1.69%. This is comparable to the rest of the industry: AHCO outperforms 55.00% of its industry peers.
AHCO has a Return On Equity of 4.83%. This is comparable to the rest of the industry: AHCO outperforms 60.00% of its industry peers.
AHCO has a Return On Invested Capital (4.53%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AHCO is below the industry average of 9.19%.
The 3 year average ROIC (4.25%) for AHCO is below the current ROIC(4.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.69%
ROE 4.83%
ROIC 4.53%
ROA(3y)-4%
ROA(5y)-3.64%
ROE(3y)-12.78%
ROE(5y)-15.4%
ROIC(3y)4.25%
ROIC(5y)3.76%
AHCO Yearly ROA, ROE, ROICAHCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

Looking at the Profit Margin, with a value of 2.33%, AHCO is in the better half of the industry, outperforming 63.00% of the companies in the same industry.
In the last couple of years the Profit Margin of AHCO has declined.
AHCO has a Operating Margin of 7.82%. This is in the better half of the industry: AHCO outperforms 74.00% of its industry peers.
In the last couple of years the Operating Margin of AHCO has grown nicely.
AHCO's Gross Margin of 25.32% is in line compared to the rest of the industry. AHCO outperforms 53.00% of its industry peers.
In the last couple of years the Gross Margin of AHCO has grown nicely.
Industry RankSector Rank
OM 7.82%
PM (TTM) 2.33%
GM 25.32%
OM growth 3Y1.95%
OM growth 5Y11.03%
PM growth 3Y-23.99%
PM growth 5YN/A
GM growth 3Y4.28%
GM growth 5Y4.45%
AHCO Yearly Profit, Operating, Gross MarginsAHCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

2

2. Health

2.1 Basic Checks

AHCO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AHCO has more shares outstanding
The number of shares outstanding for AHCO has been increased compared to 5 years ago.
Compared to 1 year ago, AHCO has an improved debt to assets ratio.
AHCO Yearly Shares OutstandingAHCO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AHCO Yearly Total Debt VS Total AssetsAHCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.08, we must say that AHCO is in the distress zone and has some risk of bankruptcy.
AHCO's Altman-Z score of 1.08 is on the low side compared to the rest of the industry. AHCO is outperformed by 72.00% of its industry peers.
The Debt to FCF ratio of AHCO is 9.48, which is on the high side as it means it would take AHCO, 9.48 years of fcf income to pay off all of its debts.
AHCO has a Debt to FCF ratio (9.48) which is comparable to the rest of the industry.
AHCO has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.27, AHCO is not doing good in the industry: 64.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF 9.48
Altman-Z 1.08
ROIC/WACC0.56
WACC8.02%
AHCO Yearly LT Debt VS Equity VS FCFAHCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.33 indicates that AHCO should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.33, AHCO is in line with its industry, outperforming 48.00% of the companies in the same industry.
AHCO has a Quick Ratio of 1.09. This is a normal value and indicates that AHCO is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.09, AHCO perfoms like the industry average, outperforming 43.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.09
AHCO Yearly Current Assets VS Current LiabilitesAHCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 119.39% over the past year.
Measured over the past years, AHCO shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.23% on average per year.
AHCO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.72%.
Measured over the past years, AHCO shows a very strong growth in Revenue. The Revenue has been growing by 43.84% on average per year.
EPS 1Y (TTM)119.39%
EPS 3Y10.23%
EPS 5YN/A
EPS Q2Q%6.67%
Revenue 1Y (TTM)-19.72%
Revenue growth 3Y9.93%
Revenue growth 5Y43.84%
Sales Q2Q%1.79%

3.2 Future

Based on estimates for the next years, AHCO will show a very strong growth in Earnings Per Share. The EPS will grow by 20.59% on average per year.
Based on estimates for the next years, AHCO will show a small growth in Revenue. The Revenue will grow by 7.27% on average per year.
EPS Next Y19.85%
EPS Next 2Y31.12%
EPS Next 3Y26.83%
EPS Next 5Y20.59%
Revenue Next Year-0.06%
Revenue Next 2Y3.16%
Revenue Next 3Y4.99%
Revenue Next 5Y7.27%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AHCO Yearly Revenue VS EstimatesAHCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
AHCO Yearly EPS VS EstimatesAHCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 -2

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 33.13 indicates a quite expensive valuation of AHCO.
Compared to the rest of the industry, the Price/Earnings ratio of AHCO is on the same level as its industry peers.
When comparing the Price/Earnings ratio of AHCO to the average of the S&P500 Index (27.25), we can say AHCO is valued slightly more expensively.
AHCO is valuated reasonably with a Price/Forward Earnings ratio of 10.28.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AHCO indicates a rather cheap valuation: AHCO is cheaper than 90.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.98. AHCO is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 33.13
Fwd PE 10.28
AHCO Price Earnings VS Forward Price EarningsAHCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AHCO is valued cheaply inside the industry as 94.00% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, AHCO is valued cheaply inside the industry as 94.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.73
EV/EBITDA 5.31
AHCO Per share dataAHCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as AHCO's earnings are expected to grow with 26.83% in the coming years.
PEG (NY)1.67
PEG (5Y)N/A
EPS Next 2Y31.12%
EPS Next 3Y26.83%

0

5. Dividend

5.1 Amount

No dividends for AHCO!.
Industry RankSector Rank
Dividend Yield 0%

ADAPTHEALTH CORP

NASDAQ:AHCO (1/12/2026, 8:00:00 PM)

After market: 10.6 0 (0%)

10.6

+0.11 (+1.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-23 2026-02-23/amc
Inst Owners93.73%
Inst Owner Change0.04%
Ins Owners1.81%
Ins Owner Change-0.06%
Market Cap1.44B
Revenue(TTM)3.26B
Net Income(TTM)75.81M
Analysts81.43
Price Target13.52 (27.55%)
Short Float %8.81%
Short Ratio8.87
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-123.07%
Min EPS beat(2)-210.83%
Max EPS beat(2)-35.31%
EPS beat(4)1
Avg EPS beat(4)-384.03%
Min EPS beat(4)-1325.49%
Max EPS beat(4)35.5%
EPS beat(8)1
Avg EPS beat(8)-358.04%
EPS beat(12)3
Avg EPS beat(12)-235.24%
EPS beat(16)3
Avg EPS beat(16)-191.39%
Revenue beat(2)1
Avg Revenue beat(2)-0.88%
Min Revenue beat(2)-2.38%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)-0.19%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.28%
Revenue beat(8)4
Avg Revenue beat(8)-0.23%
Revenue beat(12)5
Avg Revenue beat(12)-0.64%
Revenue beat(16)7
Avg Revenue beat(16)-0.16%
PT rev (1m)0%
PT rev (3m)0.95%
EPS NQ rev (1m)-4.44%
EPS NQ rev (3m)-14%
EPS NY rev (1m)-3.42%
EPS NY rev (3m)-11.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE 33.13
Fwd PE 10.28
P/S 0.44
P/FCF 6.73
P/OCF 2.52
P/B 0.91
P/tB N/A
EV/EBITDA 5.31
EPS(TTM)0.32
EY3.02%
EPS(NY)1.03
Fwd EY9.73%
FCF(TTM)1.57
FCFY14.85%
OCF(TTM)4.2
OCFY39.64%
SpS24.04
BVpS11.6
TBVpS-8.93
PEG (NY)1.67
PEG (5Y)N/A
Graham Number9.14
Profitability
Industry RankSector Rank
ROA 1.69%
ROE 4.83%
ROCE 6.5%
ROIC 4.53%
ROICexc 4.66%
ROICexgc 17.24%
OM 7.82%
PM (TTM) 2.33%
GM 25.32%
FCFM 6.55%
ROA(3y)-4%
ROA(5y)-3.64%
ROE(3y)-12.78%
ROE(5y)-15.4%
ROIC(3y)4.25%
ROIC(5y)3.76%
ROICexc(3y)4.34%
ROICexc(5y)3.9%
ROICexgc(3y)17.05%
ROICexgc(5y)18.83%
ROCE(3y)6.1%
ROCE(5y)5.39%
ROICexgc growth 3Y0.25%
ROICexgc growth 5Y-13.24%
ROICexc growth 3Y18.04%
ROICexc growth 5Y-2.96%
OM growth 3Y1.95%
OM growth 5Y11.03%
PM growth 3Y-23.99%
PM growth 5YN/A
GM growth 3Y4.28%
GM growth 5Y4.45%
F-Score7
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF 9.48
Debt/EBITDA 3.16
Cap/Depr 94.9%
Cap/Sales 10.93%
Interest Coverage 2.41
Cash Conversion 90.37%
Profit Quality 281.18%
Current Ratio 1.33
Quick Ratio 1.09
Altman-Z 1.08
F-Score7
WACC8.02%
ROIC/WACC0.56
Cap/Depr(3y)94.46%
Cap/Depr(5y)82.09%
Cap/Sales(3y)11.04%
Cap/Sales(5y)9.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)119.39%
EPS 3Y10.23%
EPS 5YN/A
EPS Q2Q%6.67%
EPS Next Y19.85%
EPS Next 2Y31.12%
EPS Next 3Y26.83%
EPS Next 5Y20.59%
Revenue 1Y (TTM)-19.72%
Revenue growth 3Y9.93%
Revenue growth 5Y43.84%
Sales Q2Q%1.79%
Revenue Next Year-0.06%
Revenue Next 2Y3.16%
Revenue Next 3Y4.99%
Revenue Next 5Y7.27%
EBIT growth 1Y-29.64%
EBIT growth 3Y12.08%
EBIT growth 5Y59.71%
EBIT Next Year166.06%
EBIT Next 3Y46.84%
EBIT Next 5YN/A
FCF growth 1Y594.38%
FCF growth 3Y48.23%
FCF growth 5Y43.24%
OCF growth 1Y34.71%
OCF growth 3Y25.26%
OCF growth 5Y55.08%

ADAPTHEALTH CORP / AHCO FAQ

What is the ChartMill fundamental rating of ADAPTHEALTH CORP (AHCO) stock?

ChartMill assigns a fundamental rating of 4 / 10 to AHCO.


What is the valuation status of ADAPTHEALTH CORP (AHCO) stock?

ChartMill assigns a valuation rating of 6 / 10 to ADAPTHEALTH CORP (AHCO). This can be considered as Fairly Valued.


How profitable is ADAPTHEALTH CORP (AHCO) stock?

ADAPTHEALTH CORP (AHCO) has a profitability rating of 5 / 10.


What is the valuation of ADAPTHEALTH CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ADAPTHEALTH CORP (AHCO) is 33.13 and the Price/Book (PB) ratio is 0.91.